Idorsia Ltd. provided earnings guidance for the year 2022. Guidance for 2022: US GAAP operating loss of around CHF 840 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 CHF | +0.49% |
|
+3.61% | -3.50% |
Jun. 13 | Idorsia Ltd Approves Board Appointments | CI |
Jun. 03 | Idorsia Ltd. Announces New Data with Daridorexant to Be Presented at Sleep 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.50% | 413M | |
+15.36% | 121B | |
+18.27% | 112B | |
+4.43% | 22.57B | |
-18.23% | 20.82B | |
-14.89% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+2.14% | 13.17B | |
+24.25% | 11.11B |
- Stock Market
- Equities
- IDIA Stock
- News Idorsia Ltd
- Idorsia Ltd Provides Earnings Guidance for the Year 2022